Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor
Highlights from EHA 2016 press briefings: POLLUX and EURO-SKI trials and BiTE antibodies
When should we start treatment for relapsed multiple myeloma patients?
Topics in multiple myeloma discussed at ASCO 2016
Highlights from ASH 2016: whole-genome sequencing to identify genomic lesions in ALL